Cannabis use in persons with traumatic spinal cord injury in Denmark

Andresen, Sven Robert; Biering‐Sørensen, Fin; Hagen, Ellen Merete; Nielsen, Jørgen Feldbæk; Bach, Flemming W.; Finnerup, Nanna Brix

doi:10.2340/16501977-2105

Cited by 16 publications

(24 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The current study should be considered in the light of the following limitations. The 41% response rate, whilst low does reflect other cross‐sectional studies in this cohort with published response rates below 50% (Heutink et al., ; Andresen et al., ). Although members of SII with no pain presentations were encouraged to complete the survey, it is possible in the absence of pain individuals may not have been as motivated to respond.…”

Section: Discussionsupporting

confidence: 51%

Quality of life after spinal cord injury: The impact of pain

Burke

Lennon

Fullen

2018

European Journal of Pain

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 51%

Quality of life after spinal cord injury: The impact of pain

Burke

Lennon

Fullen

2018

European Journal of Pain

View full text Add to dashboard Cite

show abstract

“…For the participants in this research, cannabis was a broadly positive and useful intervention for managing SCI pain. Several surveys have also reported that cannabis has a positive effect on managing pain in SCI [13,15,24]. In a survey of individuals with SCI in Denmark, (n = 537), 59% reported a positive effect on pain and spasticity [24].…”

Section: Discussionmentioning

confidence: 99%

Using cannabis for pain management after spinal cord injury: a qualitative study

Bourke

Catherwood

Nunnerley

et al. 2019

Spinal Cord Ser Cases

View full text Add to dashboard Cite

Study design A descriptive qualitative study. Objectives To explore why individuals with spinal cord injury (SCI) choose to use cannabis to manage their pain and their experiences in doing so. Setting Community-dwelling adults with SCI in New Zealand. Methods Semi-structured interviews were conducted with individuals who had a SCI, experienced pain, and self-reported use of cannabis to manage their pain. Interviews were recorded, transcribed, and subject to thematic analysis. Results Eight individuals participated in this study. We interpreted six themes that captured the participants' perspectives regarding their choice to, and perceptions of, using cannabis to manage SCI pain. Participants were motivated to use cannabis when other pain management strategies had been ineffective and were well-informed, knowledgeable cannabis consumers. Participants reported cannabis reduced their pain quickly and enabled them to engage in activities of daily living and participate in life roles without the drowsiness of traditional prescribed pain medication. Despite the positive aspects, participants were concerned about the irregularity of supply and inconsistent dosage. Conclusions Findings show that cannabis is used to reduce pain after SCI and enable increased community participation. Findings suggest that future studies examining the efficacy of cannabinoids in managing pain include function and participation outcome measures rather than solely focusing on measuring pain intensity. Focusing on meaningful outcomes may contribute to a greater understanding of the experiences of people with SCI.

show abstract

“…Third, while other studies have documented MCs' usefulness in reducing use of other medications and in treating chronic pain, this is the first study to compare perceived effectiveness of MC to prescription medications in treating SCI-related symptoms. While Drossel et al, Andresen et al, and Hawley et al documented reasons for MC among individuals with SCI [26,27,29], only Cardenas et al [28] and Andresen interrogated its perceived efficacy in relieving pain. None of these studies asked subjects to directly compare MCs' perceived efficacy and tolerability with that of prescription medications.…”

Section: Discussionmentioning

confidence: 99%

“…This study utilized a cross sectional multi-center survey methodology that has been described in our prior publication [30]. The authors reviewed existing surveys and manuscripts [1,3,26,27,31] addressing perceived risks and benefits of MC use, utilization patterns among MC users, and primary reasons for use of MC. We also used established pain and quality of life questionnaires taken from the International Spinal Cord Injury Pain and Quality of Life Basic Data Sets [32,33].…”

Section: Survey Developmentmentioning

confidence: 99%

“…Drossel et al surveyed 244 community dwelling individuals with SCI, finding that just under one-quarter used cannabis and that many sought relief from pain (70.4%) and spasticity (46.3%) [26]. Andresen et al reported that among 48 active cannabis users with SCI in Denmark, pain and spasticity were the second and third most cited reasons for use and nearly 60% described their symptom relief as "good" or "very good" [27]. In a survey of 147 individuals with SCI, Cardenas et al [28] found that just under 20% were current MC users and that while it afforded substantial pain relief, most reported that it lasted just hours.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Utilization of medicinal cannabis for pain by individuals with spinal cord injury

Stillman

Capron

Mallow

et al. 2019

Spinal Cord Ser Cases

View full text Add to dashboard Cite

Study design A cross-sectional multi-center study using an on-line survey addressing utilization, knowledge, and perceptions of medicinal cannabis (MC) by people with spinal cord injury (SCI). Objective To characterize differences between current (CU), past (PU), and never users (NU) of MC with SCI; to determine why people with SCI use MC; to examine reports of MCs' efficacy and tolerability by individuals with SCI. Setting Three academic medical centers in the United States. Methods Comparison of demographic and attitudinal differences between CU, PU, and NU and differences in the groups' reports of pain, health, and quality of life (QOL). Evaluation of utilization patterns and perceived efficacy of MC among CU and PU and reports of side effects of MC versus prescription medications. Data were analyzed using either Chi Square, distribution-free exact statistics, or t-tests for continuous data. Results Among a nationwide sample (n = 353) of individuals with SCI, NU were less likely than CU and PU to believe that cannabis ought to be legalized and more likely to endorse risks of use. Current users and PU reported greater pain interference in daily life than did NU, but there were no between group differences in QOL or physical or emotional health. Current users and PU took MC to address pain (65.30%), spasms (63.30%), sleeplessness (32.70%), and anxiety (24.00%), and 63.30% reported it offered "great relief" from symptoms. Participants reported that MC is more effective and carries fewer side effects than prescription medications. Conclusions Medicinal cannabis is an effective and well-tolerated treatment for a number of SCI-related symptoms.

show abstract

Cannabis use in persons with traumatic spinal cord injury in Denmark

Cited by 16 publications

References 34 publications

Quality of life after spinal cord injury: The impact of pain

Quality of life after spinal cord injury: The impact of pain

Using cannabis for pain management after spinal cord injury: a qualitative study

Utilization of medicinal cannabis for pain by individuals with spinal cord injury

Contact Info

Product

Resources

About